𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Recurrence-free survival after liver transplantation for small hepatocellular carcinoma

✍ Scribed by W. O. Bechstein; O. Guckelberger; N. Kling; N. Rayes; S. G. Tullius; H. Lobeck; T. Vogl; S. Jonas; P. Neuhaus


Publisher
Springer
Year
1998
Tongue
English
Weight
145 KB
Volume
11
Category
Article
ISSN
0934-0874

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Late Recurrence of Hepatocellular Carcin
✍ Kenneth S. H. Chok; See Ching Chan; Tan To Cheung; Albert C. Y. Chan; Sheung Tat πŸ“‚ Article πŸ“… 2011 πŸ› Springer 🌐 English βš– 246 KB

## Background Long-term survival of patients with hepatocellular carcinoma (HCC) after liver transplantation is affected mainly by recurrence of HCC. There is the opinion that the chance of recurrence after 2Β years post-transplantation is remote, and therefore lifelong surveillance is not justified

Impact of pretransplantation transarteri
✍ Thomas Decaens; FranΓ§oise Roudot-Thoraval; Solange Bresson-Hadni; Carole Meyer; πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 English βš– 115 KB

The actual impact of transarterial chemoembolization before liver transplantation (LT) for hepatocellular carcinoma (HCC) on patient survival and HCC recurrence is not known. Between 1985 and 1998, 479 patients with HCC in 14 French centers were evaluated for LT. Among these 479 patients, this case-

Prognostic factors affecting survival af
✍ Woo Young Shin; Kyung-Suk Suh; Hae Won Lee; Joohyun Kim; Taehoon Kim; Nam-Joon Y πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 154 KB πŸ‘ 1 views

Liver transplantation is regarded as an effective treatment for early hepatocellular carcinoma (HCC). However, some patients experience recurrence and subsequently rapid progression of the disease. We investigated prognostic factors affecting survival after recurrence in patients who underwent adult

Living donor liver transplantation for h
✍ Khashayar Vakili; James J. Pomposelli; Yee Lee Cheah; Mohamed Akoad; W. David Le πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 157 KB

In regions with a limited deceased donor pool, living donor adult liver transplantation (LDALT) has become an important treatment modality for patients with hepatocellular carcinoma (HCC) and cirrhosis. Studies have shown higher recurrence rates of HCC after LDALT in comparison with deceased donor l